×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Atrion Stock Forecast, Price & News

$635.68
+6.82 (+1.08%)
(As of 07/1/2022 08:44 PM ET)
Add
Compare
Today's Range
$629.90
$635.68
50-Day Range
$605.00
$678.75
52-Week Range
$585.27
$805.62
Volume
3,800 shs
Average Volume
4,247 shs
Market Capitalization
$1.14 billion
P/E Ratio
34.05
Dividend Yield
1.23%
Price Target
N/A

Atrion MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
4.94% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.57 out of 5 stars

Medical Sector

948th out of 1,412 stocks

Surgical & Medical Instruments Industry

96th out of 136 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive ATRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.

Atrion logo

About Atrion (NASDAQ:ATRI) Stock

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

ATRI Stock News Headlines

Atrion Reports First Quarter 2022 Results
Atrion declares $1.95 dividend
Atrion: Q4 Earnings Snapshot
Atrion Reports Fourth Quarter and Full Year 2021 Results
Atrion Corporation
Atrion Stock Is Estimated To Be Fairly Valued
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ATRI
CUSIP
04990410
Employees
667
Year Founded
N/A

Company Calendar

Last Earnings
5/09/2022
Ex-Dividend for 6/30 Dividend
6/14/2022
Dividend Payable
6/30/2022
Today
7/03/2022
Next Earnings (Estimated)
8/08/2022
Fiscal Year End
12/31/2022

Profitability

Net Income
$33.06 million
Pretax Margin
22.73%

Debt

Sales & Book Value

Annual Sales
$165.01 million
Cash Flow
$25.51 per share
Book Value
$135.67 per share

Miscellaneous

Free Float
1,388,000
Market Cap
$1.14 billion
Optionable
Not Optionable
Beta
0.17














Atrion Frequently Asked Questions

How has Atrion's stock price performed in 2022?

Atrion's stock was trading at $704.90 at the beginning of 2022. Since then, ATRI shares have decreased by 9.8% and is now trading at $635.68.
View the best growth stocks for 2022 here
.

When is Atrion's next earnings date?

Atrion is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for Atrion
.

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) released its quarterly earnings results on Monday, May, 9th. The medical instruments supplier reported $4.71 earnings per share for the quarter. The medical instruments supplier earned $47.14 million during the quarter. Atrion had a trailing twelve-month return on equity of 13.94% and a net margin of 19.56%.
View Atrion's earnings history
.

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion declared a quarterly dividend on Tuesday, May 24th. Investors of record on Wednesday, June 15th will be given a dividend of $1.95 per share on Thursday, June 30th. This represents a $7.80 annualized dividend and a dividend yield of 1.23%. The ex-dividend date of this dividend is Tuesday, June 14th.
View Atrion's dividend history
.

Is Atrion a good dividend stock?

Atrion(NASDAQ:ATRI) pays an annual dividend of $7.80 per share and currently has a dividend yield of 1.23%. Atrion has been increasing its dividend for 19 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Atrion is 41.78%. This payout ratio is at a healthy, sustainable level, below 75%.
View Atrion's dividend history.

Who are Atrion's key executives?

Atrion's management team includes the following people:
  • Mr. Emile A. Battat, Exec. Chairman (Age 84, Pay $666.55k)
  • Mr. David A. Battat, Pres & CEO (Age 52, Pay $1.94M)
  • Mr. Jeffery Strickland, CFO, VP, Treasurer & Sec. (Age 63, Pay $986.38k)

What is David A. Batta's approval rating as Atrion's CEO?

1 employees have rated Atrion CEO David A. Batta on Glassdoor.com. David A. Batta has an approval rating of 100% among Atrion's employees. This puts David A. Batta in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP), AT&T (T), WestRock (WRK), AbbVie (ABBV), Caterpillar (CAT), Eastman Chemical (EMN), Gilead Sciences (GILD), Altria Group (MO), Pfizer (PFE) and Philip Morris International (PM).

What is Atrion's stock symbol?

Atrion trades on the NASDAQ under the ticker symbol "ATRI."

How do I buy shares of Atrion?

Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Atrion's stock price today?

One share of ATRI stock can currently be purchased for approximately $635.68.

How much money does Atrion make?

Atrion (NASDAQ:ATRI) has a market capitalization of $1.14 billion and generates $165.01 million in revenue each year. The medical instruments supplier earns $33.06 million in net income (profit) each year or $18.67 on an earnings per share basis.

How many employees does Atrion have?

Atrion employs 667 workers across the globe.

How can I contact Atrion?

Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The official website for Atrion is www.atrioncorp.com. The medical instruments supplier can be reached via phone at (972) 390-9800, via email at ir-info@atrioncorp.com, or via fax at 972-396-7581.

This page (NASDAQ:ATRI) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.